Eledon Pharmaceuticals, Inc. (ELDN)
NASDAQ·Healthcare·Biotechnology
$3.77
+8.33%
Mkt Cap $205.63M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$5.00
Range $5.00 – $5.00
Implied Upside
+32.6%
Consensus $5.00 vs current $3.77
NASDAQ·Healthcare·Biotechnology
$3.77
+8.33%
Mkt Cap $205.63M
No recent rating data.
Price Target (2 analysts)
$5.00
Range $5.00 – $5.00
+32.6%
Consensus $5.00 vs current $3.77